Search research articles
Contact Us
Filters
Showing results (1-10 of 68) with videos related to
Page
of 7
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
November 19, 2024
Humans and Rodents: The Case of hOAT4 and mOat5
Pierantonio Menna, Emanuela Salvatorelli
Chemotherapy
|
January 26, 2017
Primary Prevention Strategies for Anthracycline Cardiotoxicity: A Brief Overview
Pierantonio Menna, Emanuela Salvatorelli
Chemical Research in Toxicology
|
December 4, 2009
Anthracycline degradation in cardiomyocytes: a journey to oxidative survival
Pierantonio Menna, Emanuela Salvatorelli, Giorgio Minotti
Chemotherapy
|
March 24, 2017
Do You Know Pixantrone?
Giorgio Minotti, Pierantonio Menna, Emanuela Salvatorelli
Chemical Research in Toxicology
|
April 29, 2009
4'-Epidoxorubicin to re-explore anthracycline degradation in cardiomyocytes
Pierantonio Menna, Emanuela Salvatorelli, Giorgio Minotti
Journal of Cardiovascular Pharmacology
|
October 4, 2023
Anthracyclines and Cardiotoxicity: Is CARP a Forgotten Biomarker?
Giorgio Minotti, Emanuela Salvatorelli, Pierantonio Menna
Current Cardiology Reports
|
April 17, 2019
Correction to: Cardiotoxicity of Targeted Cancer Drugs: Concerns, "The Cart Before the Horse," and Lessons from Trastuzumab
Pierantonio Menna, Giorgio Minotti, Emanuela Salvatorelli
Chemotherapy
|
April 2, 2023
New Targeted Drugs for Acute Myeloid Leukemia and Antifungals: Pharmacokinetic Challenges and Opportunities
Emanuela Salvatorelli, Giorgio Minotti, Pierantonio Menna
Expert Opinion on Drug Safety
|
July 13, 2017
Cancer drugs and QT prolongation: weighing risk against benefit
Pierantonio Menna, Emanuela Salvatorelli, Giorgio Minotti
Chemical Research in Toxicology
|
July 16, 2016
Rethinking Drugs from Chemistry to Therapeutic Opportunities: Pixantrone beyond Anthracyclines
Pierantonio Menna, Emanuela Salvatorelli, Giorgio Minotti
Page
of 7
Search research articles
Search
Showing results (1-10 of 68) with videos related to
Sort By:
Page
of 7
The Journal of Pharmacology and Experimental Therapeutics
|
November 19, 2024
Humans and Rodents: The Case of hOAT4 and mOat5
Pierantonio Menna, Emanuela Salvatorelli
Chemotherapy
|
January 26, 2017
Primary Prevention Strategies for Anthracycline Cardiotoxicity: A Brief Overview
Pierantonio Menna, Emanuela Salvatorelli
Chemical Research in Toxicology
|
December 4, 2009
Anthracycline degradation in cardiomyocytes: a journey to oxidative survival
Pierantonio Menna, Emanuela Salvatorelli, Giorgio Minotti
Chemotherapy
|
March 24, 2017
Do You Know Pixantrone?
Giorgio Minotti, Pierantonio Menna, Emanuela Salvatorelli
Chemical Research in Toxicology
|
April 29, 2009
4'-Epidoxorubicin to re-explore anthracycline degradation in cardiomyocytes
Pierantonio Menna, Emanuela Salvatorelli, Giorgio Minotti
Journal of Cardiovascular Pharmacology
|
October 4, 2023
Anthracyclines and Cardiotoxicity: Is CARP a Forgotten Biomarker?
Giorgio Minotti, Emanuela Salvatorelli, Pierantonio Menna
Current Cardiology Reports
|
April 17, 2019
Correction to: Cardiotoxicity of Targeted Cancer Drugs: Concerns, "The Cart Before the Horse," and Lessons from Trastuzumab
Pierantonio Menna, Giorgio Minotti, Emanuela Salvatorelli
Chemotherapy
|
April 2, 2023
New Targeted Drugs for Acute Myeloid Leukemia and Antifungals: Pharmacokinetic Challenges and Opportunities
Emanuela Salvatorelli, Giorgio Minotti, Pierantonio Menna
Expert Opinion on Drug Safety
|
July 13, 2017
Cancer drugs and QT prolongation: weighing risk against benefit
Pierantonio Menna, Emanuela Salvatorelli, Giorgio Minotti
Chemical Research in Toxicology
|
July 16, 2016
Rethinking Drugs from Chemistry to Therapeutic Opportunities: Pixantrone beyond Anthracyclines
Pierantonio Menna, Emanuela Salvatorelli, Giorgio Minotti
Page
of 7